Central serous chorioretinopathy in a COVID-19-positive patient

Abstract

A 37-year-old healthy male presented with sudden loss of vision in the left eye (LE) 1 week following starting oral steroids for COVID-19 complications. Best-corrected visual acuity in the left eye (LE) was 20/80, N12. Clinical and imaging tests led to a diagnosis of central serous chorioretinopathy in the LE. There was gradual resolution of neurosensory detachment following the discontinuation of steroid therapy. Two months following initial presentation, best-corrected visual acuity in the LE had improved to 20/20, N6.

Keywords

• central serous chorioretinopathy
• covid-19
• oral steroids